A novel leukocyte chemotactic and activating cytokine, interleukin-8 (IL-8).
Mukaida
N
N
Department of Pharmacology, Kanazawa University, Ishikawa, Japan.
Harada
A
A
Matsushima
K
K
D000208:Acute Disease; D000595:Amino Acid Sequence; D000818:Animals; D015703:Antigens, CD / Q000737:chemistry / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D001483:Base Sequence; D002634:Chemotaxis, Leukocyte / Q000187:drug effects / Q000502:physiology*; D004285:Dogs; D005786:Gene Expression Regulation; D018390:Gene Targeting; D006801:Humans; D007239:Infections / Q000503:physiopathology; D007249:Inflammation / Q000503:physiopathology; D016209:Interleukin-8 / Q000737:chemistry / Q000235:genetics / Q000494:pharmacology / Q000502:physiology*; D008213:Lymphocyte Activation / Q000502:physiology*; D051379:Mice; D008958:Models, Molecular; D011487:Protein Conformation; D011817:Rabbits; D051381:Rats; D018123:Receptors, Interleukin / Q000737:chemistry / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D023062:Receptors, Interleukin-8A; D016415:Sequence Alignment; D017386:Sequence Homology, Amino Acid; D015398:Signal Transduction / Q000502:physiology
D015703:Antigens, CD; D016209:Interleukin-8; D018123:Receptors, Interleukin; D023062:Receptors, Interleukin-8A